Calvert Investment Management’s CVS Health CVS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q1
Sell
-230,346
Closed -$18.2M 160
2016
Q4
$18.2M Sell
230,346
-13,402
-5% -$1.08M 0.68% 23
2016
Q3
$21.7M Sell
243,748
-16,365
-6% -$1.54M 0.8% 18
2016
Q2
$24.9M Sell
260,113
-49,602
-16% -$4.94M 1% 11
2016
Q1
$32.1M Sell
309,715
-49,902
-14% -$4.85M 1.42% 10
2015
Q4
$35.2M Buy
359,617
+26,742
+8% +$2.62M 1.6% 6
2015
Q3
$32.1M Buy
332,875
+29,189
+10% +$3.07M 1.6% 11
2015
Q2
$31.9M Buy
303,686
+170,555
+128% +$17.4M 1.41% 19
2015
Q1
$13.7M Sell
133,131
-601
-0.4% -$60.8K 0.89% 26
2014
Q4
$12.9M Sell
133,732
-65,023
-33% -$5.73M 0.88% 26
2014
Q3
$15.8M Sell
198,755
-74,396
-27% -$5.86M 1.17% 14
2014
Q2
$20.6M Sell
273,151
-31,732
-10% -$2.4M 1.38% 20
2014
Q1
$22.8M Sell
304,883
-174,776
-36% -$12.3M 1.61% 10
2013
Q4
$34.3M Buy
479,659
+275,735
+135% +$17.7M 2.5% 2
2013
Q3
$11.6M Sell
203,924
-2,645
-1% -$158K 1.44% 4
2013
Q2
$11.8M Buy
+206,569
New +$12M 1.61% 5

Other funds holding CVS

Calvert Investment Management's CVS Position: Q1 2017 in Review

Calvert Investment Management sold out of CVS Health (CVS) in Q1 2017, closing a stake of 230,346 shares — an estimated $18.2M sold.

Calvert Investment Management first reported a position in CVS in Q2 2013 and held it in 15 quarters. The position peaked at $35.2M in Q4 2015. 1,575 funds tracked by Wall St. Rank hold CVS as of Q1 2017.

  • Calvert Investment Management reported no remaining CVS Health position as of Q1 2017 after selling out during the quarter.
  • Calvert Investment Management sold 230,346 CVS Health shares in Q1 2017, an estimated $18.2M.
  • Calvert Investment Management first reported a position in CVS Health in Q2 2013 and held it in 15 quarters.
  • Calvert Investment Management's CVS Health position peaked at $35.2M in Q4 2015.
  • 1,575 funds tracked by Wall St. Rank held CVS Health as of Q1 2017.

Based on Calvert Investment Management's 13F filing for Q1 2017.